Prostate cancer screening and diagnosis
Early screening and diagnosis is important for the successful treatment of prostate cancer and to ensure the best possible outcome.
PSA test for Prostate Cancer
A PSA test is a blood test that measures the level of PSA - Prostate Specific Antigen – in a man’s blood. PSA is a protein made by the prostate which naturally leaks into the bloodstream. After testing, if a man’s levels of PSA are said to be ‘raised’, it could be a sign that he has prostate cancer. However, a raised PSA level can also indicate that another, non-cancerous prostate condition exists, such as benign enlargement of the prostate and prostatitis (inflammation of the prostate). Following a raised PSA test result, often the only way to definitely determine whether prostate cancer exists is through a biopsy.
Because of the uncertainties that are often associated with PSA testing, and the need for a biopsy, Mr Bhanot now offers his patients the PCA3 test.
PCA3 test for prostate cancer
This test helps to diagnose prostate cancer more accurately, often without the need for a biposy. The PCA3 tests the urine for the presence of PCA3, the prostate cancer-specific gene, which is present in much higher levels in prostate cancer tissues than in normal prostate tissues. The PCA3 test is specific in determining the presence of the prostate cancer gene, and, unlike the PSA test, will normally NOT pick up genes relating to benign prostate conditions. This gene-based test can be used to diagnose new cases of prostate cancer, and also for men who have had back previous biopsies with a negative result who want further reassurance.
(NB: The PCA3 test has not yet been approved by NICE within the NHS, so please check with your insurers if you are covered for this procedure.)
Mr Bhanot carries out the above tests for prostate cancer in the comfort of Spire Roding Hospital.
Read more about cancer tests available at Spire Roding Hospital.